Mitchell Allen Gevelber, MD
Adolescent Medicine · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 2
- 1 carrier
- Office
- 1
Offices
1 location
Plans that list them
2 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Gevelber’s office at (408) 885-5445 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
California Medical Board record
Licence A70083 · Current
Licensed to practise in California · since 1999 · expires 2027-07-31 · Case Western Reserve University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Medicaid work
$364,027 in 2024
Medicaid paid $364,027 for 5,422 billed services this clinician did in 2024, up to 64 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 668 | $358,447 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 620 | $2,763 |
| Infectious agent detection by nucleic acid (DNA or RNA); Neisseria gonorrhoeae, amplified probe technique | 17 | $656 |
| Infectious agent detection by nucleic acid (DNA or RNA); Chlamydia trachomatis, amplified probe technique | 16 | $636 |
| Service | 28 | $606 |
| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, 50 mcg/0.5 mL dosage, for intramuscular use | 13 | $338 |
| Short return visit (20+ min) | 331 | $196 |
| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, 30 mcg/0.3 mL dosage, tris-sucrose formulation, for intramuscular use | 19 | $131 |
| Screening test, pure tone, air only | 137 | $129 |
| URINE PREGNANCY TEST | 44 | $123 |
| Pain severity quantified; no pain present (COA) (ONC) | 25 | $0 |
| Medication list documented in medical record (COA) | 683 | $0 |
| 2024 | 5,422 | 21 | 64 | $364,027 |
| 2023 | 2,462 | 15 | 41 | $339,099 |
| 2022 | 2,022 | 17 | 46 | $227,968 |
| 2021 | 1,850 | 10 | 62 | $277,930 |
| 2020 | 653 | 4 | 40 | $130,814 |
| 2019 | 1,697 | 9 | 40 | $234,281 |
| 2018 | 2,687 | 14 | 112 | $341,099 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 641 | $324,632 |
| Short return visit | 86 | $4,699 |
| Infectious agent detection by nucleic acid (DNA or RNA); Chlamydia trachomatis, amplified probe technique | 57 | $2,257 |
| Infectious agent detection by nucleic acid (DNA or RNA); Neisseria gonorrhoeae, amplified probe technique | 58 | $2,229 |
| Service | 102 | $2,209 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 417 | $2,104 |
| Short return visit (20+ min) | 193 | $318 |
| URINE PREGNANCY TEST | 132 | $315 |
| Screening test, pure tone, air only | 188 | $259 |
| Bilateral quantitative screening test of visual acuity | 84 | $46 |
| Meningococcal conjugate vaccine, serogroups A, C, W, Y, quadrivalent, tetanus toxoid carrier (MenACWY-TT), for intramuscular use | 23 | $16 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 136 | $16 |
2022
| Clinic visit/encounter, all-inclusive | 435 | $220,757 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 420 | $2,663 |
| Infectious agent detection by nucleic acid (DNA or RNA); Chlamydia trachomatis, amplified probe technique | 27 | $1,074 |
| Infectious agent detection by nucleic acid (DNA or RNA); Neisseria gonorrhoeae, amplified probe technique | 27 | $1,042 |
| Service | 42 | $910 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, bivalent spike protein, preservative free, 30 mcg/0.3 mL dosage, tris-sucrose formulation, booster dose | 14 | $560 |
| Short return visit (20+ min) | 103 | $480 |
| Short return visit | 39 | $275 |
| URINE PREGNANCY TEST | 52 | $91 |
| Screening test, pure tone, air only | 130 | $81 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 178 | $20 |
| Human Papillomavirus vaccine types 6, 11, 16, 18, 31, 33, 45, 52, 58, nonavalent (9vHPV), 2 or 3 dose schedule, for intramuscular use | 78 | $10 |
2021
| Clinic visit/encounter, all-inclusive | 558 | $275,625 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 358 | $1,659 |
| Short return visit (20+ min) | 191 | $604 |
| Short return visit | 22 | $41 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 181 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 168 | $0 |
| Meningococcal recombinant protein and outer membrane vesicle vaccine, serogroup B (MenB-4C), 2 dose schedule, for intramuscular use | 93 | $0 |
| Human Papillomavirus vaccine types 6, 11, 16, 18, 31, 33, 45, 52, 58, nonavalent (9vHPV), 2 or 3 dose schedule, for intramuscular use | 53 | $0 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 164 | $0 |
| Meningococcal conjugate vaccine, serogroups A, C, W, Y, quadrivalent, diphtheria toxoid carrier (MenACWY-D) or CRM197 carrier (MenACWY-CRM), for intramuscular use | 62 | $0 |
2020
| Clinic visit/encounter, all-inclusive | 389 | $130,183 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 114 | $515 |
| Short return visit (20+ min) | 72 | $74 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 78 | $41 |
2019
| Clinic visit/encounter, all-inclusive | 604 | $206,186 |
| Short return visit (20+ min) | 402 | $16,132 |
| Infectious agent detection by nucleic acid (DNA or RNA); Chlamydia trachomatis, amplified probe technique | 90 | $3,699 |
| Infectious agent detection by nucleic acid (DNA or RNA); Neisseria gonorrhoeae, amplified probe technique | 90 | $3,589 |
| Service | 159 | $3,444 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 111 | $533 |
| URINE PREGNANCY TEST | 126 | $353 |
| Unclassified drugs | 15 | $346 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 100 | $0 |
2018
| Clinic visit/encounter, all-inclusive | 925 | $300,231 |
| Short return visit (20+ min) | 349 | $15,958 |
| Infectious agent detection by nucleic acid (DNA or RNA); Chlamydia trachomatis, amplified probe technique | 283 | $8,651 |
| Infectious agent detection by nucleic acid (DNA or RNA); Neisseria gonorrhoeae, amplified probe technique | 283 | $8,406 |
| Service | 198 | $4,289 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 90 | $1,007 |
| Return visit (30+ min) | 79 | $719 |
| Unclassified drugs | 42 | $657 |
| URINE PREGNANCY TEST | 265 | $517 |
| Long return visit (40+ min) | 33 | $473 |
| Screening test, pure tone, air only | 83 | $191 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use | 16 | $0 |
Professional record
- NPI
- 1326001298
- Licence
- CA A70083California A70083: Current · expires 2027-07-31
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00A700830
- Taxonomy
- Federal specialty code 2080A0000X (2080A0000X); Pediatrics (208000000X)
- Mailing address
- 1027 Daisy Ct, Sunnyvale, CA, 94086
- NPI first listed
- 2006-04-10
- NPI last updated
- 2012-10-05
This is when the NPI record was last certified, not a medical board exam.